Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Photo of Gregory S. Calip

Gregory S. Calip


Affiliate, Center for Pharmacoepidemiology and Pharmacoeconomic Research
Director, UIC-AbbVie Fellowship in Pharmacovigilance and Patient Safety
Member, Cancer Prevention and Control Research Program
Associate Professor, Pharmacy Systems, Outcomes and Policy

Related Sites:

Teaching and Supervision Heading link

Ph.D. Thesis Research (PSOP 599), 1/10/2022 – 4/29/2022
Epidemiology/Biostatistics (PHAR 439), 1/10/2022 – 2/11/2022
Epidemiology/Biostatistics (PHAR 439), 1/10/2022 – 2/11/2022
Independent Study (PSOP 596), 1/10/2022 – 4/29/2022
Ph.D. Thesis Research (PSOP 599), 8/23/2021 – 12/3/2021
Independent Study (PSOP 596), 8/23/2021 – 12/3/2021
Independent Study (PSOP 596), 6/14/2021 – 8/6/2021
Epidemiology/Biostatistics (PHAR 439), 1/11/2021 – 2/12/2021
Ph.D. Thesis Research (PSOP 599), 1/11/2021 – 4/30/2021

Selected Grants

3/3: The Chicago Cancer Health Equity Collaborative (ChicagoCHEC), National Institutes of Health (National Cancer Institute)., 9/22/2020 - 8/31/2025, Obligated Amount: $2805763; Anticipated Amount: $6834852

Increasing the cure fraction in myeloma- a novel strategy to personalize melphalan dosing and overcome DNA repair-mediated resistance, UIC College of Pharmacy., 8/1/2020 - 7/31/2021, Obligated Amount: $25000; No Anticipated Amount Set

Pilot Study to Develop and Test a Multiplex Assay for CYP450 Phenotyping in Multiple Myeloma Patients Receiving Bortezomib, Hematology Oncology Pharmacy Association (HOPA)., 3/1/2020 - 2/28/2022, Obligated Amount: $85283; Anticipated Amount: $85283

Prevention of Venous Thromboembolism in Multiple Myeloma: The Thromboprophylaxis Multi-Cohort Study, National Institutes of Health., 12/2019 - 11/2023, No Obligated Amount Set; No Anticipated Amount Set

UIC Subaward for Dental prescribing of antibiotics and opioids: high use in the absence of evidence, University of Pittsburgh., 11/1/2019 - 7/31/2021, Obligated Amount: $360368; Anticipated Amount: $360368

Surveillance, Epidemiology, and End Results based Real-World Evidence in EArLy Breast Cancer (SEER-REAL-BC) Studies: Patient Characteristics, Treatment Patterns, and Outcomes in Patients with HR+/HER2- early-stage breast cancer, Pfizer., 8/19/2019 - 8/19/2021, No Obligated Amount Set; No Anticipated Amount Set

Pfizer outcomes research agreement, Pfizer Inc., 8/19/2019 - 8/19/2021, Obligated Amount: $396464; Anticipated Amount: $396464

Clinical outcomes among older women with early stage HR-positive, HER2-negative breast cancer in the United States, Pfizer, Inc. HEOR., 7/2019 - 6/2021, No Obligated Amount Set; No Anticipated Amount Set

Mechanisms of human lymphatic dysfunction in Alzheimer's disease, National Institutes of Health., 7/2019 - 6/2024, No Obligated Amount Set; No Anticipated Amount Set

Selected Publications

Huang, Hsiao-Ching, Smart, Mary H, Zolekar, Ashwini, Deng, Huiwen, Hubbard, Colin C, Hoskins, Kent F, Ko, Naomi Y, Guadamuz, Jenny S, Calip, Gregory S. (2022). Impact of socioeconomic status and rurality on cancer-specific survival among women with de novo metastatic breast cancer by race/ethnicity. Breast Cancer Research and Treatment, 1-10. doi:10.1007/s10549-022-06603-6.

Coleman, Chandler, Yan, Connie H, Ko, Naomi Y, Nabulsi, Nadia A, Hoskins, Kent F, Chiu, Brian C-H, Calip, Gregory S. (2022). Physical functioning, frailty and risks of locally-advanced breast cancer among older women. The Breast, 64, 19-28. doi:10.1016/j.breast.2022.04.005.

Wang, Xiaoliang, Cho-Phan, Cheryl D, Hoskins, Kent F, Calip, Gregory S. (2022). Understanding Racial and Ethnic Inequities in Uptake and Outcomes Following Multigene Prognostic Testing in Early Breast Cancer: The Promise of Real-World Data.. Cancer Epidemiology Biomarkers & Prevention, 31, (4), 704-706. doi:10.1158/1055-9965.epi-22-0066.

Sweiss, Karen, Kurzweil, Kaily, Calip, Gregory, Sharp, Lisa, Nabulsi, Nadia, Rondelli, Damiano, Patel, Pritesh Rajni. (2022). 516 Chronic Opioid Use Is Highly Prevalent in Allogeneic Transplant Recipients and Impacts Long Term Outcomes. Transplantation and Cellular Therapy, 28, (3), s403-s404. doi:10.1016/s2666-6367(22)00675-3.

Calip, Gregory S, Nabulsi, Nadia A, Hubbard, Colin, Asfaw, Alemseged A, Lee, Inyoung, Zhou, Jifang, Cueto, Jenilee, Mitra, Debanjali, Ko, Naomi Y, Hoskins, Kent F, Law, Ernest H. (2022). Impact of time to distant recurrence on breast cancer-specific mortality in hormone receptor-positive breast cancer. Cancer Causes & Control, 33, (5), 793-799. doi:10.1007/s10552-022-01561-2.

Yan, Connie H, Lee, Todd A, Sharp, Lisa K, Hubbard, Colin C, Evans, Charlesnika T, Calip, Gregory S, Rowan, Susan A, McGregor, Jessina C, Gellad, Walid F, Suda, Katie J. (2022). Trends in Opioid Prescribing by General Dentists and Dental Specialists in the U.S., 2012–2019. American Journal of Preventive Medicine. doi:10.1016/j.amepre.2022.01.009.

Huang, Hsiao-Ching, Calip, Gregory S, Weiss, Jennifer, Simons, Yael, Gadi, VK, Danciu, Oana C, Rauscher, Garth H, Hoskins, Kent F. (2022). Abstract P3-14-02: Racial/ethnic differences in the benefit of adjuvant chemotherapy for breast cancer patients with an intermediate risk 21-gene recurrence score. Cancer Research, 82, (4_Supplement), p3-14-02-p3-14-02. doi:10.1158/1538-7445.sabcs21-p3-14-02.

Hubbard, Colin C, Evans, Charlesnika T, Calip, Gregory S, Zhou, Jifang, Rowan, Susan A, Suda, Katie J. (2022). Appropriateness of Antibiotic Prophylaxis Before Dental Procedures, 2016–2018. American Journal of Preventive Medicine. doi:10.1016/j.amepre.2021.11.004.

Parikh, Ravi B, Takvorian, Samuel U, Vader, Daniel, Paul Wileyto, E, Clark, Amy S, Lee, Daniel J, Goyal, Gaurav, Rocque, Gabrielle B, Dotan, Efrat, Geynisman, Daniel M, Phull, Pooja, Spiess, Philippe E, Kim, Roger Y, Davidoff, Amy J, Gross, Cary P, Neparidze, Natalia, Miksad, Rebecca A, Calip, Gregory S, Hearn, Caleb M, Ferrell, Will, Shulman, Lawrence N, Mamtani, Ronac, Hubbard, Rebecca A. (2021). Impact of the COVID-19 Pandemic on Treatment Patterns for Patients With Metastatic Solid Cancer in the United States.. Journal of the National Cancer Institute, 114, (4), 571-578. doi:10.1093/jnci/djab225.

Professional Leadership

NIH Center for Scientific Review, 9/7/2020 - 9/9/2020

Education

Degrees:
PharmD, University of Illinois at Chicago, United States, 2008
MPH, New York University, United States, 2010
PhD, University of Washington, United States, 2014

Postgraduate Training:
NCI Cancer Prevention Training Grant in Nutrition, Exercise and Genetics, Fred Hutchinson Cancer Research Center, United States, 2014

Licensures and Certifications

Registered Pharmacist, Washington State, Date Not Set - Present
Registered Pharmacist, New York State, Date Not Set - Present
Registered Pharmacist, Illinois State, Date Not Set - Present
Immunization Provider, APhA, Date Not Set - Present
CPR-AED Training, American Red Cross, Date Not Set - Present
Pharmacy Provider, NPI, Date Not Set - Present